Patent · US Active

Polypeptides binding to human complement C5

US9808502B2 · kind B2 · utility

4Cited by

1References

35Claims

0Family size

Assignee

SWEDISH ORPHAN BIOVITRUM AG · SE

Inventors

Charlotta Berghard · Stockholm, SE
Magnus Berglund · Handen, SE
Patrik Strömberg · Sollentuna, SE
Malin Lindborg · Boo, SE
Elin Gunneriusson · Hallsberg, SE
Joachim Feldwisch · Tyresö, SE

Key dates

Filing date	Feb 19, 2013
Grant date	Nov 7, 2017
Priority date	—
Expiry date	Feb 25, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/31
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to C5 binding polypeptides, comprising a C5 binding motif, BM, which motif consists of an amino acid sequence selected from i) EX2X3X4A X6X7EID X11LPNL X16X17X18QW X21AFIX25X26LX28D, and ii) an amino acid sequence which has at least 86% identity to the sequence defined in i), wherein the polypeptide binds to C5. The present invention moreover relates to C5 binding polypeptides for use in therapy, such as for use in treatment of a C5 related condition, and to methods of treatments.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.